Teva Pharmaceutical Industries Insider Sold Shares Worth $414,270, According to a Recent SEC Filing-February 2024-www.financetom.com

Teva Pharmaceutical Industries Insider Sold Shares Worth $414,270, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Teva Pharmaceutical Industries Insider Sold Shares Worth $414,270, According to a Recent SEC Filing

Mar 5, 2024 2:02 PM

04:30 PM EST, 03/05/2024 (MT Newswires) -- Richard D Francis, President and CEO, on March 03, 2024, sold 31,061 shares in Teva Pharmaceutical Industries ( TEVA ) for $414,270. Following the Form 4 filing with the SEC, Francis has control over a total of 123,295 shares of the company, with 123,295 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/818686/000095017024026008/xslF345X03/ownership.xml

Previous page： PROG Holdings's Q3 Adjusted Earnings Fall, Revenue Increases; Updates 2024 Guidance Next page： US lab operator Quest Diagnostics to launch bird flu test at end of October

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

PROG Holdings's Q3 Adjusted Earnings Fall, Revenue Increases; Updates 2024 Guidance

Oct 23, 2024

08:04 AM EDT, 10/23/2024 (MT Newswires) -- PROG Holdings ( PRG ) reported Q3 adjusted earnings Wednesday of $0.77 per diluted share, down from $0.90 a year earlier. Analysts polled by Capital IQ expected $0.80. Revenue for the quarter ended Sept. 30 was $606.1 million compared with $582.9 million a year earlier. Analysts surveyed by Capital IQ expected $602.4 million....

US lab operator Quest Diagnostics to launch bird flu test at end of October

Oct 23, 2024

Oct 23 - Lab operator Quest Diagnostics ( DGX ) said on Wednesday it will launch a test for H5N1 bird flu at the end of October after the U.S. Centers for Disease Control and Prevention (CDC) gave it contracts to support testing for two emerging infectious diseases, including the Oropouche virus. WHY IT'S IMPORTANT The spread of bird flu...

GE Vernova Q3 Earnings: Strong Sales, Earnings Miss, Cash Flow Surge & More

Oct 23, 2024

GE Vernova Inc. ( GEV ) shares are trading lower in premarket after the company reported mixed third-quarter results. The company reported revenue growth of 8% year-over-year to $8.913 billion and +10% YoY organically, beating the consensus of $8.783 billion. “GE Vernova had a solid third quarter, delivering double-digit orders and continued revenue growth with services strength across all segments,...

Unilever's pricing shift may have attracted shoppers in third quarter

Oct 23, 2024

LONDON (Reuters) - Investors are looking to Unilever's ( UL ) third-quarter results on Thursday to see if the consumer goods group has started to claw back some market share lost to cheaper rivals as it seeks to balance sales volumes and margins. The packaged food industry, including Unilever ( UL ), had to raise prices to cope with cost...